학술논문
Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial
Document Type
Article
Author
Source
In Journal of Clinical Lipidology January-February 2020 14(1):88-97
Subject
Language
ISSN
1933-2874